Ciphergen Completes Exchange of $27.5 Million of Its Outstanding 4.5% Convertible Senior Notes
16 Novembro 2006 - 12:00PM
PR Newswire (US)
FREMONT, Calif., Nov. 16 /PRNewswire-FirstCall/ -- Ciphergen
Biosystems, Inc. (NASDAQ:CIPH) announced today that it has
completed the exchange of its outstanding 4.50% Convertible Senior
Notes due 2008 (the "Outstanding Notes") as previously agreed to by
separate privately negotiated agreements with certain holders.
$27.5 million aggregate principal amount of Outstanding Notes were
exchanged for $16.5 million of a new series of 7.00% Convertible
Senior Notes due 2011 (the "New Notes") and $11.0 million of cash.
The New Notes issuable in the exchange transactions and the common
stock issuable upon conversion of the New Notes have not been
registered under the Securities Act of 1933 (the "Securities Act")
or the securities laws of any state and, unless so registered, may
not be offered or sold in the United States except pursuant to an
applicable exemption from the registration requirement of the
Securities Act and applicable state securities laws. This press
release shall not constitute an offer to sell or the solicitation
of an offer to buy any of these securities. DATASOURCE: Ciphergen
Biosystems, Inc. CONTACT: Sue Carruthers, Investor Relations of
Ciphergen Biosystems, Inc., +1-510-505-2233; or Daryl Messinger,
Media of WeissComm Partners, +1-415-946-1062, for Ciphergen
Biosystems, Inc. Web site: http://www.ciphergen.com/
Copyright
Ciphergen Biosystems (NASDAQ:CIPH)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Ciphergen Biosystems (NASDAQ:CIPH)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024
Notícias em tempo-real sobre Ciphergen Biosystems (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Ciphergen Biosystems (MM)